Quantification of Myocardial Extracellular Volume Fraction in Systemic AL Amyloidosis-Reference-Cited by-同舟云学术

Quantification of Myocardial Extracellular Volume Fraction in Systemic AL Amyloidosis

Published:2013-01 Issue:1 Volume:6 Page:34-39
ISSN:1941-9651
Container-title:Circulation: Cardiovascular Imaging
language:en
Short-container-title:Circ Cardiovasc Imaging

Author:

Banypersad Sanjay M.¹,Sado Daniel M.¹,Flett Andrew S.¹,Gibbs Simon D.J.¹,Pinney Jennifer H.¹,Maestrini Viviana¹,Cox Andrew T.¹,Fontana Marianna¹,Whelan Carol J.¹,Wechalekar Ashutosh D.¹,Hawkins Philip N.¹,Moon James C.¹

Affiliation:

1. From the The Heart Hospital (S.M.B., D.M.S., A.S.F., V.M., A.T.C., M.F., J.C.M.); The National Amyloidosis Centre, Royal Free Hospital (S.M.B., S.D.J.G., J.H.P., M.F., C.J.W., A.D.W., P.N.H.); and Institute of Cardiovascular Science, University College London, (S.M.B., D.M.S., J.C.M.) London, United Kingdom.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Reference23 articles.

1. Primary systemic amyloidosis: clinical and laboratory features in 474 cases.;Kyle RA;Semin Hematol,1995

2. Variant-Sequence Transthyretin (Isoleucine 122) in Late-Onset Cardiac Amyloidosis in Black Americans

3. Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

4. Increases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis

5. Electrophysiologic Abnormalities in AL (Primary) Amyloidosis With Cardiac Involvement

Cited by 276 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myocardial fibrosis from the perspective of the extracellular matrix: Mechanisms to clinical impact;Matrix Biology;2024-12

2. DPD Quantification Correlates With Extracellular Volume and Disease Severity in Wild-Type Transthyretin Cardiac Amyloidosis;JACC: Advances;2024-10

3. Defining echocardiographic predictors of outcome in cardiac amyloidosis by subtype;Current Problems in Cardiology;2024-09

4. Clinical Applications of Cardiac Magnetic Resonance Parametric Mapping;Diagnostics;2024-08-20

5. Epidemiology, diagnosis, and management of cardiac amyloidosis;Journal of Investigative Medicine;2024-08-06